Hypothesis: Transplanted osteoprogenitor cells derived from cultured bone m
arrow stromal cells (BMSCs) can be used to fabricate pedicled bone flaps.
Design: Prospective, randomized experimental trials.
Setting: Basic science research laboratory.
Materials: Immunodeficient female NIH-Bg-Nu-Xid mice, aged 3 months.
Intervention: The BMSCs were harvested from the long bones of C57B1/6 trans
genic mice carrying the type I alpha (1) collagen-chloramphenicol acetyl tr
ansferase reporter gene construct; their numbers were expanded in tissue cu
lture. Treated mice received BMSC transplantations around the common caroti
d artery and internal jugular vein, the aorta and its venae comitantes, or
the saphenous artery and vein; control mice received a sham transplant in c
omparable recipient sites.
Main Outcome Measures: Mice underwent harvesting from 4 weeks to 2 years af
ter transplantation. Transplants were evaluated via histological, immunohis
tochemical, and angiographic analyses.
Results: Compared with the controls, which formed no bone, 32 of 37 BMSC-co
ntaining transplants formed a vascularized bone island that was perfused sp
ecifically and solely by its common carotid artery vascular source. Mature
transplants consisted of well-developed lamellar, corticocancellous bone wh
ose osteocytes were derived from the grafted BMSCs; hematopoietic tissue de
rived from the recipient mouse. Transplants formed as early as 4 weeks and
remained stable in size as late as 108 weeks.
Conclusions: Bone marrow stromal cells can be used to create vascularized b
one flaps in mice; these bone constructs are vascularized by their pedicle
and therefore can potentially be transferred to a recipient site using micr
osurgical techniques. These findings provide proof of principle of an addit
ional clinical application of BMSC transplantation techniques.